Profile data is unavailable for this security.
About the company
Amniotics AB (publ) is a Sweden-based biotech company that develops cell therapy drugs based on mesenchymal stem cells from amniotic fluid in its in-house GMP licensed facility. Amniotics' own marker technology is used to identify and select stem cells for different tissue types; Lung (PulmoStem), Brain (CogniStem), Kidney (NephroStem), Skin (CutiStem). It allows for selecting the type of cell to be used for specific tissue. The company has developed a process - patented in all steps - which includes collection of amniotic fluid, with a medical device developed by Amniotics, followed by sorting and propagation of stem cells and packaging of product in ampoules in its own GMP facility. Amniotics is a technology and service provider to Universities, Hospitals, and the Biopharmaceutical industry.
- Revenue in SEK (TTM)0.00
- Net income in SEK-30.87m
- Incorporated2015
- Employees6.00
- LocationAmniotics AB (publ)Medicon Village, Scheelevagen 2LUND 223 63SwedenSWE
- Websitehttps://www.amniotics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bio Vitos Pharma AB | 2.98m | -12.87m | 3.71m | 1.00 | -- | 0.9649 | 7.23 | 1.24 | -0.2547 | -0.2547 | 0.0533 | 0.1119 | 0.0989 | 0.00 | 5.38 | 2,983,990.00 | -42.63 | -31.11 | -44.50 | -32.92 | 100.00 | -- | -431.21 | -1,026.76 | 4.27 | -- | 0.00 | -- | 126.97 | -- | 13.64 | -- | -- | -- |
European Institute of Science AB | 686.00k | -2.76m | 5.15m | 0.00 | -- | 1.97 | -- | 7.51 | -4.23 | -4.23 | 1.05 | 1.93 | 0.2435 | 1.24 | 9.46 | -- | -97.91 | -93.04 | -105.11 | -103.14 | 59.33 | 67.01 | -402.04 | -518.82 | 5.70 | -- | 0.00 | -- | 13.69 | 8.54 | 0.4062 | -- | -- | -- |
QuiaPEG Pharmaceuticals Holding AB | 0.00 | -16.52m | 5.50m | 8.00 | -- | 0.3605 | -- | -- | -3.51 | -3.51 | 0.00 | 0.2047 | 0.00 | -- | -- | -- | -50.53 | -95.67 | -100.54 | -207.86 | -- | 262.59 | -- | -5,002.50 | -- | -15.34 | 0.00 | -- | -- | -- | 17.75 | -- | 47.06 | -- |
XP Chemistries AB | 663.69k | -8.04m | 5.79m | 2.00 | -- | 0.2255 | -- | 8.73 | -0.2846 | -0.2846 | 0.0213 | 0.275 | 0.023 | 0.2084 | 5.99 | 331,845.00 | -27.79 | -- | -29.36 | -- | 50.57 | -- | -1,211.24 | -- | 5.79 | -- | 0.00 | -- | -37.14 | -- | -1.55 | -- | -- | -- |
2cureX AB | 155.00k | -30.82m | 6.18m | -- | -- | 0.4513 | -- | 39.86 | -1.75 | -1.75 | 0.0088 | 0.7777 | 0.0048 | -- | 0.0838 | -- | -95.89 | -38.21 | -108.66 | -43.48 | -6,889.68 | -22,153.06 | -19,883.23 | -38,685.30 | -- | -46.08 | -- | -- | 72.22 | -- | -3.52 | -- | -- | -- |
Lipidor AB | 77.00k | -11.49m | 6.81m | -- | -- | -- | -- | 88.44 | -0.3964 | -0.3964 | 0.0027 | -0.3223 | 0.0084 | -- | 5.31 | -- | -124.54 | -59.41 | -- | -75.10 | -- | -- | -14,916.88 | -643.36 | -- | -- | -- | -- | 73.33 | -20.33 | 72.24 | -- | -- | -- |
Stayble Therapeutics AB | 0.00 | -23.74m | 8.36m | 3.00 | -- | 0.5063 | -- | -- | -0.9492 | -0.9492 | 0.00 | 0.5204 | 0.00 | -- | -- | 0.00 | -116.21 | -78.64 | -141.76 | -95.58 | -- | -- | -- | -- | -- | -- | 0.049 | -- | -- | -- | 3.22 | -- | -- | -- |
Eurocine Vaccines AB | 5.00k | -15.06m | 8.71m | 3.00 | -- | -- | -- | 1,742.53 | -0.1472 | -0.1472 | 0.00005 | -0.0018 | 0.0007 | -- | 0.002 | -- | -199.76 | -83.17 | -323.19 | -97.89 | -199,780.00 | -- | -301,180.00 | -- | -- | -- | -- | -- | -- | -- | 8.95 | -- | -- | -- |
Carbiotix AB (publ) | 1.47m | -13.48m | 8.83m | 10.00 | -- | 0.1284 | -- | 6.03 | -0.302 | -0.302 | 0.0324 | 0.3817 | 0.0586 | -- | 2.36 | 146,552.00 | -53.88 | -49.38 | -64.85 | -55.50 | 235.45 | 574.69 | -919.76 | -1,828.86 | -- | -76.28 | 0.1384 | -- | 259.56 | -12.04 | -10.02 | -- | 13.64 | -- |
Amniotics AB (publ) | 0.00 | -30.87m | 10.66m | 6.00 | -- | 0.6803 | -- | -- | -0.0374 | -0.0374 | 0.00 | 0.0057 | 0.00 | -- | -- | 0.00 | -112.25 | -101.09 | -362.71 | -149.92 | -- | -- | -- | -- | 1.12 | -16.17 | -- | -- | -- | -- | 35.75 | -- | -- | -- |
Diagonal Bio AB | 23.00k | -11.68m | 13.62m | 4.00 | -- | 0.1056 | -- | 592.25 | -0.1982 | -0.1982 | 0.0004 | 0.3221 | 0.0007 | -- | 2.00 | 5,750.00 | -37.35 | -- | -44.49 | -- | -41,604.35 | -- | -50,769.57 | -- | 0.5105 | -104.20 | -- | -- | -88.67 | -- | 27.75 | -- | -- | -- |